• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adapting therapy with repeated short-infusions to inter individual variability between patients.

作者信息

Rosca I D, Vergnaud J M

机构信息

Department of Polymer Chemistry, Polytechnic University, Bucharest, Romania.

出版信息

Eur J Drug Metab Pharmacokinet. 2007 Apr-Jun;32(2):87-99. doi: 10.1007/BF03190997.

DOI:10.1007/BF03190997
PMID:17702196
Abstract

Because of the wide inter individual variability between patients and their marked differences in drug response, one of the major issues that arises is adapting the therapy in question to the particular patient. In hospital, it is possible to vary the conditions of intravenous (i.v.) drug delivery by means of short infusions repeated at certain intervals. In this study, review of this process has been presented, and a therapeutic method described. It essentially consists of two stages. The first concerns the time of the first infusion, and the course of drug elimination: from two analyses of the drug concentrations in the blood made at two different times, the pharmacokinetic parameters of the patient are determined. Stage 2 consists of repeated short infusions and the therapy is adapted to the particular patient by varying the conditions involved. Thus, either the amount of the dose based on the rate of infusion or the time interval between the repeated infusions are varied. In order to reach a general solution, master curves are built by using dimensionless numbers as co-ordinates, such as time expressed in terms of the half-life t0.5 of the drug, and the drug concentration at the peaks defined as a fraction of the first unchanged peak concentration.

摘要

相似文献

1
Adapting therapy with repeated short-infusions to inter individual variability between patients.
Eur J Drug Metab Pharmacokinet. 2007 Apr-Jun;32(2):87-99. doi: 10.1007/BF03190997.
2
Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.利用药代动力学-药效学关系预测依从性差的影响。
Clin Pharmacokinet. 2002;41(1):1-6. doi: 10.2165/00003088-200241010-00001.
3
The effect of infusion time on the time course of drug concentration in blood.
J Pharmacokinet Biopharm. 1980 Dec;8(6):573-82. doi: 10.1007/BF01060054.
4
Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.多次静脉注射和口服给药后药代动力学数据的非房室分析
Pharmazie. 1997 Jul;52(7):529-32.
5
A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.经皮药物吸收的非线性双吸附二维数学模型。
Biomed Eng Online. 2005 Jul 3;4:40. doi: 10.1186/1475-925X-4-40.
6
Prediction of infusion rates: computer study.输注速率的预测:计算机研究
Br J Anaesth. 1990 Mar;64(3):283-6. doi: 10.1093/bja/64.3.283.
7
Safety and pharmacokinetics of paracetamol following intravenous administration of 5 g during the first 24 h with a 2-g starting dose.在最初24小时内以2克起始剂量静脉注射5克对乙酰氨基酚后的安全性和药代动力学。
Clin Pharmacol Ther. 2007 Mar;81(3):401-5. doi: 10.1038/sj.clpt.6100064.
8
Pharmacokinetic-pharmacodynamic relationship.药代动力学-药效学关系
Ann Rech Vet. 1990;21 Suppl 1:29S-40S.
9
Dosage regimen calculations with optimal control theory.
Int J Biomed Comput. 1994 Jun;36(1-2):87-93. doi: 10.1016/0020-7101(94)90098-1.
10
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.全人源抗TNF-α单克隆抗体戈利木单抗在类风湿关节炎患者中的药代动力学及安全性
J Clin Pharmacol. 2007 Mar;47(3):383-96. doi: 10.1177/0091270006298188.

引用本文的文献

1
Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug.综述:与药物相关的口腔扩散控制释放剂型特性的计算
Eur J Drug Metab Pharmacokinet. 2010 Sep;35(1-2):29-39. doi: 10.1007/s13318-010-0005-x.